Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This open-label study is to determine the safety and efficacy of momelotinib in participants with either polycythemia vera (PV) or essential thrombocythemia (ET) who have not yet received treatment with a Janus kinase (JAK) inhibitor.
Epistemonikos ID: 0c6d80bf767920c4064863f1ce0da15f2bc2e538
First added on: May 11, 2024